×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中南大学 [12]
内容类型
期刊论文 [12]
发表日期
2017 [3]
2016 [2]
2015 [1]
2014 [5]
2012 [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共12条,第1-10条
帮助
限定条件
专题:中南大学
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation study
期刊论文
Journal of Hematology & Oncology, 2017, 卷号: 10, 期号: 1, 页码: 137
作者:
Hou, Jian*
;
Jin, Jie
;
Xu, Yan
;
Wu, Depei
;
Ke, Xiaoyan
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/12/03
China
Ixazomib
Multiple myeloma
Oral
Overall survival
Progression-free survival
Proteasome inhibitor
Relapsed/refractory
BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1/ERK/ELK1 signaling in hepatocellular carcinoma
期刊论文
Cancer Letters, 2017, 卷号: 411, 页码: 117-129
作者:
Ma, Junli
;
Zeng, Shan
;
Zhang, Yan
;
Deng, Ganlu
;
Qu, Yanling
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/12/03
Bone morphogenetic protein 4
Epithelial-mesenchymal transition
ELK1
Hepatocellular carcinoma
Oxaliplatin
AFP
alpha-fetoprotein
ANLT
adjacent non-tumorous liver tissue
BMP4
Bone morphogenetic protein 4
DCR
disease control rate
EMT
epithelial-mesenchymal transition
HCC
hepatocellular carcinoma
IHC
immunohistochemistry
MMP
matrix metalloproteinase
OS
overall survival
PFS
progression free survival
RFA
radiofrequency ablation
RR
Response rate
siRNA
short interfering RNA
TACE
transarterial chemoembolization
TUNEL
TdT-mediated dUTP nick end-labeling
Combination of metformin with chemotherapeutic drugs via different molecular mechanisms
期刊论文
Cancer Treatment Reviews, 2017, 卷号: 54, 页码: 24-33
作者:
Peng, Mei*
;
Darko, Kwame Oteng
;
Tao, Ting
;
Huang, Yanjun
;
Su, Qiongli
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2019/12/03
AIs
aromatase inhibitors
AMPK
Adenosine Monophosphate-Activated Protein Kinase
AR
androgen
ATM
Ataxia Telangiectasia Mutated
ATP
Adenosine Triphosphate
BCSS
breast cancer specific survival
CK-MB
Creatine Kinase-MB
CREB1
cAMP Response Element-Binding Protein 1
CSC
cancer stem cell
DFS
disease-free survival
DHFU
dihydrofluorouracil
DPD
dihydropyrimidine dehydrogenase
EpCAM
Epithelial Cell Adhesion Molecule
ER
estrogen
ERCC1
excision repair cross-complementary 1
ERK
extracellular signal-regulated kinases
EZH2
enhancer of zeste homolog 2
FdUMP
fluorodeoxyuridine monophosphate
FdUTP
fluorodeoxyuridine triphosphate
FHC
ferritin heavy chain
FUTP
fluorouridine triphosphate
HbA1C
hemoglobin A1c
HER
Human Epidermal Growth Factor Receptor
HIF-1α
hypoxia-inducible factor-1α
HK
hexokinase
IGF1R
insulin growth factor 1 receptor
LDH
lactate dehydrogenase
MDA
Muscular Dystrophy Association
MMP
Matrix Metallopeptidase
MRP1
multidrug resistance-associated protein 1
mTOR
mammalian target of rapamycin
MTX
methotrexate
NCCN
National Comprehensive Cancer Network
OS
overall survival
pCR
Pathologic Complete Response
PDGFR
platelet-derived growth factor receptors
PFS
progression-free survival
PKA
protein kinase A
PR
progesterone receptor
RFS
relapse-free survival
SOD
superoxide dismutase
TAM
tamoxifen
TCA
tricarboxlic acid
TS
thymidylate synthase
Combination
Mechanisms
Metformin
Chemotherapeutic drugs
Association of Improved Locoregional Control With Prolonged Survival in Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma
期刊论文
JAMA Oncology, 2016, 卷号: 3, 期号: 1, 页码: 83-91
作者:
Yang, Yong
;
Cao, Jian-Zhong
;
Lan, Sheng-Min
;
Wu, Jun-Xin
;
Wu, Tao
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/03
china
extranodal disease
lymphoma
natural killer t-cells
non-hodgkin's lymphoma, aggressive
progression-free survival
radiation therapy
Salt-inducible Kinase (SIK1) regulates HCC progression and WNT/β-catenin activation
期刊论文
Journal of Hepatology, 2016, 卷号: 64, 期号: 5, 页码: 1076-1089
作者:
Qu, Chao
;
He, De
;
Lu, Xiaoling
;
Dong, Lihua
;
Zhu, Yuekun
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2019/12/03
ChIP
chromatin immunoprecipitation
DFS
disease-free survival
EGF
epidermal growth factor
EMT
epithelial-mesenchymal transition
GSK-3β
glycogen synthase kinase-3β
HCC
hepatocellular carcinoma
HDAC3
histone deacetylase 3
IF
immunofluorescence
IHC
immunohistochemistry
NCoR
nuclear receptor corepressor
OS
overall survival
PCR
polymerase chain reaction
TBL1
transducin-beta-like protein 1
TBLR1
transducing-beta-like 1 X-linked receptor 1
TF
transcriptional factor
shSIK1
small hairpin RNA targeting SIK1
Salt-inducible kinase 1
Twist1
Epithelial-mesenchymal transition
β-catenin
Silencing mediator for retinoid
Thyroid receptors
Symptom and Quality of Life Improvement in LUX-Lung 6: An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non-small-cell Lung Cancer.
期刊论文
Journal of Thoracic Oncology, 2015, 卷号: 10, 期号: 6, 页码: 883-889
作者:
Geater, Sarayut L
;
Xu, Chong-Rui
;
Zhou, Caicun
;
Hu, Cheng-Ping
;
Feng, Jifeng
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/03
Afatinib
Non-small-cell lung cancer
Patient-reported outcomes
Progression-free survival
Quality of life
Nicotinamide N-methyltransferase is overexpressed in prostate cancer and correlates with prolonged progression-free and overall survival times
期刊论文
Oncology Letters, 2014, 卷号: 8, 期号: 3, 页码: 1175-1180
作者:
Zhou, Weimin
;
Gui, Ming
;
Zhu, Min
;
Long, Zhi
;
Huang, Lihua
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2019/12/03
immunohistochemistry
nicotinamide N-methyltransferase
prognosis
prostate cancer
Clinical efficacy of second-generation tyrosine kinase inhibitors in imatinib-resistant gastrointestinal stromal tumors: a meta-analysis of recent clinical trials
期刊论文
Drug design, development and therapy, 2014, 卷号: 8, 页码: 2061-2067
作者:
Wu, Lile
;
Zhang, Zhongqiang
;
Yao, Hongliang
;
Liu, Kuijie
;
Wen, Yu
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2019/12/03
Randomized controlled trials evaluating the clinical efficacy of second-generation TKIs were identified by searching PubMed and EMBASE from 2000 to February 2014. Outcomes subjected to analysis were progression-free survival and overall survival. Statistical analyses were performed using Review Manager version 5.1.0 (Cochrane Collaboration
Oxford
UK). Weighted hazard ratios (HR) with 95% confidence intervals (CIs) were calculated for the outcomes. Fixed-effects or random-effects models were used
depending on the degree of heterogeneity across the selected studies.
ERCC1 Cys8092Ala and XRCC1 Arg399Gln Polymorphisms Predict Progression-Free Survival after Curative Radiotherapy for Nasopharyngeal Carcinoma
期刊论文
PLOS ONE, 2014, 卷号: 9, 期号: 7, 页码: e101256
作者:
Jin, Hekun
;
Xie, Xiaoxue
;
Wang, Hui
;
Hu, Jun
;
Liu, Feng
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2019/12/03
Radiation therapy,DNA repair,Cancer treatment,Nasopharyngeal carcinoma,Variant genotypes,DNA damage,Heredity,Multivariate analysis
Involvement of miR-29b signaling in the sensitivity to chemotherapy in patients with ovarian carcinoma
期刊论文
Human Pathology, 2014, 卷号: 45, 期号: 6, 页码: 1285-1293
作者:
Dai, Furong
;
Zhang, Yi
;
Chen, Yuxiang*
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/12/03
Ovarian cancer
Overall survival
Progression-free survival
miR-29b
MAPK10
ATG9A
Mcl1
©版权所有 ©2017 CSpace - Powered by
CSpace